NEW YORK (GenomeWeb) – Abreos Biosciences and True Diagnostics have agreed to collaborate on the development of point-of-care tests that can validate the identity and activity of biologics and biosimilars for use in cancer, autoimmune diseases, and other chronic illnesses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.